APA (7th ed.) Citation

Li, E. W., Jones, E., Bryant, C., King, T., Talaulikar, D., Ng, J. Y., . . . Ho, P. J. (2024). A single‐day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies. European Journal of Haematology, 113(4), 521. https://doi.org/10.1111/ejh.14266

Chicago Style (17th ed.) Citation

Li, Eric Wenlong, et al. "A Single‐day Polychemotherapy Regimen with Proteasome Inhibitor Combinations for Relapsed/refractory Myeloma in the Era of Novel Therapies." European Journal of Haematology 113, no. 4 (2024): 521. https://doi.org/10.1111/ejh.14266.

MLA (9th ed.) Citation

Li, Eric Wenlong, et al. "A Single‐day Polychemotherapy Regimen with Proteasome Inhibitor Combinations for Relapsed/refractory Myeloma in the Era of Novel Therapies." European Journal of Haematology, vol. 113, no. 4, 2024, p. 521, https://doi.org/10.1111/ejh.14266.